NP2GO Review

NP2GO: an Oklahoma clinic that puts its whole price list on the table

NP2GO is one of the rare GLP-1 telehealth operations that doesn't make you fill out a quiz to find out what you'll pay. It publishes its entire per-dose pricing matrix in the open, for both semaglutide and tirzepatide, and lets you pick the payment structure that fits how you actually use the medication. If you're the kind of shopper who hates discovering the real number only after you've handed over your medical history, this is a refreshingly honest place to start. Entry compounded semaglutide runs $150 a month, which lands at the competitive low end of the market and just under the category median of $170.

It's worth knowing what NP2GO actually is, though. This isn't a venture-backed national app. It's a nurse-practitioner-led hybrid clinic founded in 2019 in Edmond, Oklahoma, that grew a telehealth arm on top of a physical practice. By its own count it has served more than 40,000 patients over seven years. That history shows up in how the business is run — straightforward, clinical, a little no-frills — rather than in slick onboarding.

Two ways to pay, and the choice genuinely matters

NP2GO gives you two pricing paths, and picking the right one can swing your monthly cost by a lot. The first is Pay As You Go: you pay per dose, scaling up as your dose climbs, plus a visit fee every three months that sits on top of the medication cost. The second is a flat Month-to-Month Membership that bundles a range of doses into one rate with no separate per-visit charge.

Here's the practical takeaway most reviews skip. Pay As You Go is cheaper at the lowest doses — semaglutide starts at $150 — but it gets expensive fast as you titrate up. High-dose tirzepatide on Pay As You Go climbs into the high-three-figure-to-six-hundred-a-month range, while the membership caps tirzepatide at a flat rate well below that for the same high doses. The rule of thumb: if you're starting out or staying on a low dose, Pay As You Go wins; once you're climbing toward maintenance doses, the membership is almost always the better deal. Run the math on both before you commit.

• Pay As You Go — per-dose pricing plus a visit fee every three months; best for low or starting doses.
• Month-to-Month Membership — one flat rate that bundles dose tiers; best once you've titrated up to higher doses.
• Both cover compounded semaglutide and compounded tirzepatide across the full dose ladder.

What you actually get: compounded GLP-1s, with prior authorizations filed for you

The medications here are compounded semaglutide and compounded tirzepatide — not brand-name pens. That keeps the price down, but it's the standard caveat for this corner of the market: compounded drugs aren't FDA-reviewed the way Wegovy or Zepbound are. NP2GO is upfront that it doesn't accept insurance for the medication itself.

What does stand out is that NP2GO files prior authorizations on your behalf. That's genuinely uncommon among compounded telehealth providers, who usually wash their hands of insurance entirely. It won't help with the compounded prescriptions, but if you and your prescriber ever pivot toward a brand-name drug your plan might cover, having a clinic that will actually do the paperwork is a real, concrete benefit most competitors don't offer.

The real differentiator: a clinician-run practice, not a checkout funnel

NP2GO's identity is its biggest selling point and its biggest limitation at the same time. Care is nurse-practitioner-led, and the clinic states its board-certified practitioners are members of the Obesity Medicine Association — a credential that signals these are people who treat obesity as their actual specialty, not a side hustle bolted onto a pharmacy. It's a woman-owned small business with a real address and phone number in Edmond, Oklahoma. For patients who want to feel like a clinic, not a cart, that texture matters.

The flip side: a lot of NP2GO's broader menu — peptide therapy, hormone services, and aesthetic treatments — is Oklahoma-only, available in person at the clinic. If you're outside Oklahoma, you're getting the weight-loss telehealth product and not much else. The virtual weight-loss visits themselves reach 39 states plus Washington, D.C.

Who should choose it, and who should look elsewhere

Choose NP2GO if you value transparent, see-it-before-you-buy pricing, you're starting at a low dose, and you like the idea of a small clinician-run practice with an obesity-medicine focus. It's also a sensible pick if you might eventually want help filing insurance paperwork.

Skip it if you live in one of the 11 states it doesn't serve — Alabama, Georgia, Indiana, Louisiana, Missouri, Mississippi, North Carolina, Ohio, South Carolina, Tennessee, or Wisconsin. Think twice if you're going straight to high-dose tirzepatide and would forget to switch to the membership tier, since Pay As You Go gets pricey at the top of the ladder. And if third-party accreditation is your dealbreaker, note the gap below.

Trust and safety: solid practice, thin public accreditation

On the reassuring side, there are no FDA warning letters on file for NP2GO, the practice has a verifiable corporate identity and a multi-year operating history, and the Obesity Medicine Association membership is a meaningful clinical signal. We live-verified its pricing and state coverage directly against its own site, and the published prices match its listings exactly with no bait-and-switch.

The honest gaps: NP2GO is not LegitScript-certified, and it doesn't publicly name its compounding pharmacy partner or disclose NABP or HIPAA accreditation on its public pages. None of that means the medication is unsafe — plenty of legitimate clinics keep their pharmacy relationships private — but it does mean you're trusting the clinic's reputation rather than a third-party seal. For more on how we weigh these factors, see our scoring methodology.

Bottom line

NP2GO is a credible, clinician-led option that earns its keep on price transparency and an obesity-medicine focus rather than national polish. The published pricing matrix and the Pay-As-You-Go-versus-membership choice are real advantages if you do five minutes of math up front; entry semaglutide at $150 is a strong starting number. The trade-offs are equally real: limited state coverage, an unnamed pharmacy, no LegitScript badge, and an out-of-state experience that's narrower than the in-clinic Oklahoma one. For low-and-mid-dose patients in a covered state who want honesty over hype, it's an easy provider to recommend taking seriously.

If you're weighing alternatives, Maximus ($149.99/month) and bmiMD ($99/month) are among the closest options we track to NP2GO.